BM
Blue Marlin Therapeutics, Inc.
SEC filingBiotechnology · Charlottesville, VA
Amount raised$100Ksold at filing
Total offeringNot stated
Investors in the raise2count reported to the SEC
FiledOct 21, 2025first sale Oct 6, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Paul ManningExecutive Officer
Sean StalfortExecutive Officer
Executive officers, directors and promoters as listed on the Form D.